IO Biotech, Inc.
IOBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $31 | $28 | $37 | $60 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $10 | $4 | $4 |
| Total Curr. Assets | $37 | $39 | $42 | $65 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $0 |
| Total NC Assets | $3 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $42 | $46 | $68 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $5 | $5 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $14 | $12 | $14 |
| Total Curr. Liab. | $18 | $20 | $18 | $19 |
| LT Debt | $1 | $8 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $20 | $13 | $0 | $0 |
| Total NC Liab. | $21 | $21 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $2 | $2 |
| Total Liabilities | $39 | $41 | $19 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $0 | $0 | $0 |
| Retained Earnings | -$416 | -$408 | -$382 | -$359 |
| AOCI | -$7 | -$7 | -$7 | -$7 |
| Other Equity | $421 | $416 | $415 | $413 |
| Total Equity | $1 | $2 | $26 | $47 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $40 | $42 | $46 | $68 |
| Net Debt | -$29 | -$20 | -$35 | -$58 |